| 1 |
21907187 | Lovastatin inhibits proliferation of anaplastic thyroid cancer cells through up-regulation of p27 by interfering with the Rho/ROCK-mediated pathway. | 2011 Dec 1 |
3 |
| 2 |
19787257 | Synergistic effects of lovastatin and celecoxib on caveolin-1 and its down-stream signaling molecules: Implications for colon cancer prevention. | 2009 Nov |
1 |
| 3 |
16094629 | Dramatic synergistic anticancer effect of clinically achievable doses of lovastatin and troglitazone. | 2006 Feb 1 |
1 |
| 4 |
16985065 | Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells. | 2006 Sep |
2 |
| 5 |
10502407 | Lovastatin inhibits G1/S transition of normal human B-lymphocytes independent of apoptosis. | 1999 Oct 10 |
1 |
| 6 |
10502413 | The biphasic induction of p21 and p27 in breast cancer cells by modulators of cAMP is posttranscriptionally regulated and independent of the PKA pathway. | 1999 Oct 10 |
1 |
| 7 |
10652602 | Lovastatin-induced inhibition of HL-60 cell proliferation via cell cycle arrest and apoptosis. | 1999 Jul-Aug |
2 |
| 8 |
9553123 | Inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells. | 1998 Apr 24 |
2 |
| 9 |
9811471 | Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53. | 1998 Nov 5 |
8 |
| 10 |
9848777 | Lovastatin inhibits mesangial cell proliferation via p27Kip1. | 1998 Dec |
2 |